Search

everythinglearnresearchcommunity

for

Search:↓

IL-17 and certain immune cells are linked to more severe alopecia areata.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

γδ T cells adapt uniquely to different tissues in mice.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Inflammation plays a key role in activating skin stem cells for hair growth and wound healing, but more research is needed to understand how it directs cell behavior.

Human amniotic stem cells can safely treat psoriasis-like skin in mice.

Ift20 is essential for hair follicle function and skin cell movement.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

New therapies are being developed that target integrin pathways to treat various diseases.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

ILC1-like cells may contribute to hair loss in alopecia areata.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.